About Vanadis Diagnostics
Vanadis Diagnostics is a company based in Sollentuna (Sweden) founded in 2013 was acquired by PerkinElmer in January 2016. Vanadis Diagnostics operates in a competitive market with competitors including Natera, BillionToOne, SYNLAB, Progenity and Sequenom, among others.
- Headquarter Sollentuna, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
PerkinElmer
(Jan 26, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Vanadis Diagnostics
Detailed funding history for Vanadis Diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Vanadis Diagnostics
Vanadis Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include PerkinElmer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical instruments and supplies are manufactured and provided for healthcare.
|
Locked | Locked | Locked |
Investor details for Vanadis Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vanadis Diagnostics
Investment portfolio details for Vanadis Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vanadis Diagnostics
Detailed financials for Vanadis Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vanadis Diagnostics Comparisons
Peer comparison for Vanadis Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vanadis Diagnostics
Vanadis Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, SYNLAB, Progenity and Sequenom, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of cell-free cancer liquid biopsy test
|
|
| Locked | Locked | Locked |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| Locked | Locked | Locked |
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
|
|
| Locked | Locked | Locked |
Molecular diagnostics for prenatal genetic testing are specialized in.
|
Detailed competitors of Vanadis Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vanadis Diagnostics
Complete news archive for Vanadis Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vanadis Diagnostics
Vanadis Diagnostics was founded in 2013.
Vanadis Diagnostics is headquartered in Sollentuna, Sweden. It is registered at Sollentuna, Stockholm County, Sweden.
Vanadis Diagnostics was founded in 2013 in Sollentuna, Sweden, and operates in the biotechnology sector focused on prenatal diagnostics. Solutions for non-invasive prenatal testing are developed, utilizing the proprietary Smart NIPT platform. Fetal cell-free DNA is isolated from maternal blood samples, amplified, and tagged with fluorescent labels to facilitate detection. Operations emphasize efficient genetic analysis for clinical applications.
Vanadis Diagnostics's top competitors include Natera, BillionToOne and Pictor.
Vanadis Diagnostics has 1 investor. Key investors include PerkinElmer.